Catalyst Biosciences Inc (CBIO)
0.194
-0.01 (-3.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.194
0.00 (0.00%)
After-Hours: 17:37
Catalyst Biosciences Shareholders Equity (Quarterly): 29.38M for Sept. 30, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | 29.38M |
June 30, 2022 | 79.06M |
March 31, 2022 | 27.08M |
December 31, 2021 | 41.09M |
September 30, 2021 | 60.74M |
June 30, 2021 | 85.16M |
March 31, 2021 | 104.09M |
December 31, 2020 | 76.07M |
September 30, 2020 | 94.06M |
June 30, 2020 | 108.96M |
March 31, 2020 | 97.52M |
December 31, 2019 | 68.34M |
September 30, 2019 | 81.27M |
June 30, 2019 | 93.11M |
March 31, 2019 | 105.81M |
December 31, 2018 | 119.94M |
September 30, 2018 | 129.95M |
June 30, 2018 | 136.96M |
March 31, 2018 | 142.85M |
December 31, 2017 | 30.77M |
September 30, 2017 | 24.88M |
June 30, 2017 | 30.35M |
March 31, 2017 | 13.84M |
December 31, 2016 | 16.07M |
September 30, 2016 | 19.60M |
Date | Value |
---|---|
June 30, 2016 | 23.48M |
March 31, 2016 | 27.99M |
December 31, 2015 | 31.42M |
September 30, 2015 | 36.21M |
June 30, 2015 | 99.53M |
March 31, 2015 | 103.23M |
December 31, 2014 | 109.08M |
September 30, 2014 | 112.91M |
June 30, 2014 | 117.02M |
March 31, 2014 | 124.10M |
December 31, 2013 | 134.61M |
September 30, 2013 | 146.73M |
June 30, 2013 | 158.18M |
March 31, 2013 | 169.46M |
December 31, 2012 | 175.92M |
September 30, 2012 | 190.57M |
June 30, 2012 | 196.36M |
March 31, 2012 | 178.70M |
December 31, 2011 | 174.29M |
September 30, 2011 | 182.01M |
June 30, 2011 | 189.10M |
March 31, 2011 | 107.56M |
December 31, 2010 | 91.85M |
September 30, 2010 | 90.36M |
June 30, 2010 | 86.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
27.08M
Minimum
Mar 2022
142.85M
Maximum
Mar 2018
88.50M
Average
93.11M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
IsoPlexis Corp | 41.27M |
Angion Biomedica Corp | 43.77M |
Apollo Endosurgery Inc | -- |
Adamis Pharmaceuticals Corp | -0.8081M |
Cardiovascular Systems Inc | 239.39M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 31.02M |
Total Liabilities (Quarterly) | 1.644M |